These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
40 related articles for article (PubMed ID: 20960741)
1. [Prostaglandin E1, E2 and their metabolites]. Kojima F; Yuhki K; Kashiwagi H; Ushikubi F Nihon Rinsho; 2010 Jul; 68 Suppl 7():20-4. PubMed ID: 20960741 [No Abstract] [Full Text] [Related]
2. [Prostaglandin E1, E2 and their metabolites]. Shio H Nihon Rinsho; 1999 Nov; 57 Suppl():724-7. PubMed ID: 10635954 [No Abstract] [Full Text] [Related]
3. Liquid chromatography and radioimmunoassay method for the determination of prostaglandins E1 and E2 in rat embryo incubates. Hotter G; Roselló-Catafau J; Closa D; Bioque G; Gelpí E; Javerbaum A; González E; Gimeno MA J Chromatogr; 1993 Nov; 655(1):85-8. PubMed ID: 8308097 [TBL] [Abstract][Full Text] [Related]
4. A novel prostaglandin metabolic pathway from a marine mollusc: prostaglandin-1,15-lactones. Di Marzo V; Cimino G; Sodano G; Spinella A; Villani G Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():129-32. PubMed ID: 1825529 [No Abstract] [Full Text] [Related]
5. Quantitative determination of prostaglandins E1, E2 and E3 in frog tissue. Herman CA; Hamberg M; Granström E J Chromatogr; 1987 May; 394(2):353-62. PubMed ID: 3497937 [TBL] [Abstract][Full Text] [Related]
6. Differential effect of prostaglandins E1 and E2 on lipopolysaccharide-induced adhesion molecule expression on human monocytes. Takahashi HK; Iwagaki H; Tamura R; Katsuno G; Xue D; Sugita S; Mori S; Yoshino T; Tanaka N; Nishibori M Eur J Pharmacol; 2005 Apr; 512(2-3):223-30. PubMed ID: 15840408 [TBL] [Abstract][Full Text] [Related]
7. [Prostaglandin E1, E2 and their metabolites]. Shio H Nihon Rinsho; 2005 Aug; 63 Suppl 8():14-6. PubMed ID: 16149439 [No Abstract] [Full Text] [Related]
8. Identity of the E-series prostaglandin produced by equine chondrocytes and synovial cells in response to a variety of stimuli. May SA; Hooke RE; Lees P Res Vet Sci; 1989 Jan; 46(1):54-7. PubMed ID: 2922506 [TBL] [Abstract][Full Text] [Related]
9. [Skeletal side effects of treatment with prostaglandin E1]. Persigehl M; Hövels-Gürich H; von Bernuth G Rofo; 1984 Oct; 141(4):427-30. PubMed ID: 6436918 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin D2 and prostaglandin E2 accelerate the recovery of cutaneous barrier disruption induced by mechanical scratching in mice. Honma Y; Arai I; Hashimoto Y; Futaki N; Sugimoto M; Tanaka M; Nakaike S Eur J Pharmacol; 2005 Jul; 518(1):56-62. PubMed ID: 16000196 [TBL] [Abstract][Full Text] [Related]
11. [Proton permeability of liposomes caused by the interaction between phosphatidylcholine and prostaglandin E1 and its analog]. Sorokina AD; Boguslavskiĭ LI; Iaĭlenko TL; Freĭmanis Ia; Sokolov GP Dokl Akad Nauk SSSR; 1988; 299(3):751-4. PubMed ID: 2841082 [No Abstract] [Full Text] [Related]
12. Prostanoid DP1 receptor agonist inhibits the pruritic activity in NC/Nga mice with atopic dermatitis. Arai I; Takano N; Hashimoto Y; Futaki N; Sugimoto M; Takahashi N; Inoue T; Nakaike S Eur J Pharmacol; 2004 Nov; 505(1-3):229-35. PubMed ID: 15556157 [TBL] [Abstract][Full Text] [Related]
13. [Double-blind study of the effect of various intra-arterial/intravenous prostaglandin E1 doses on hemodynamics and prostaglandin E1 metabolites]. Rudofsky G; Peskar BA Vasa Suppl; 1991; 33():345. PubMed ID: 1788751 [No Abstract] [Full Text] [Related]
14. Modulation of progesterone-induced Xenopus oocyte maturation by prostaglandins E1 and E2. Zhao J; Kung HF Cell Mol Biol Res; 1994; 40(1):63-8. PubMed ID: 7804327 [TBL] [Abstract][Full Text] [Related]
15. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation]. Antonikov IM; Alekseev OV; Chernukh AM Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942 [TBL] [Abstract][Full Text] [Related]
16. Alteration of the Cloudman melanoma cell cycle by prostaglandins E1 and E2 determined by using a 5-bromo-2'-deoxyuridine method of DNA analysis. Abdel-Malek ZA; Swope VB; Trinkle LS; Ferroni EN; Boissy RE; Nordlund JJ J Cell Physiol; 1988 Aug; 136(2):247-56. PubMed ID: 3137233 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunction. Cawello W; Schweer H; Dietrich B; Seyberth HW; Albrecht D; Fox A; Hohmuth H J Urol; 1997 Oct; 158(4):1403-7. PubMed ID: 9302131 [TBL] [Abstract][Full Text] [Related]
18. A radioimmunoassay for the unstable pulmonary metabolites of prostaglandin E1 and E2: an indirect index of their in vivo disposition and pharmacokinetics. Bothwell W; Verburg M; Wynalda M; Daniels EG; Fitzpatrick FA J Pharmacol Exp Ther; 1982 Feb; 220(2):229-35. PubMed ID: 6948952 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen. Bowes LG; Dumble LJ; Pollak R; Ruwart MJ; Francis DM; Hunter S; Clunie GJ Transplant Proc; 1989 Oct; 21(5):3769-70. PubMed ID: 2530676 [No Abstract] [Full Text] [Related]
20. Peripheral vasodilator effects of prostaglandins: comparison of 6-keto-prostaglandin E1 with prostacyclin and escape from prostaglandin E2 in the mesenteric vascular bed. Feigen LP; Chapnick BM; Hyman AL; King L; Marascalco B; Kadowitz PJ J Pharmacol Exp Ther; 1980 Sep; 214(3):528-34. PubMed ID: 6995573 [No Abstract] [Full Text] [Related] [Next] [New Search]